Your browser doesn't support javascript.
loading
International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature.
Prieto-Pinto, Laura; Garzón-Orjuela, Nathaly; Lasalvia, Pieralessandro; Castañeda-Cardona, Camilo; Rosselli, Diego.
Afiliação
  • Prieto-Pinto L; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
  • Garzón-Orjuela N; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia. Electronic address: nathaly03_14@hotmail.com.
  • Lasalvia P; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia; Clinical Epidemiology and Biostatistics Department, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Castañeda-Cardona C; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
  • Rosselli D; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia; Clinical Epidemiology and Biostatistics Department, Pontificia Universidad Javeriana, Bogotá, Colombia.
Value Health Reg Issues ; 23: 37-48, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32688214
OBJECTIVES: To characterize at a global level the concept of therapeutic value (TV) and describe the experience of value-based pricing (VBP) policies in 6 reference countries. METHODS: We conducted a rapid review of the literature that addressed 2 exploratory research questions. A systematic and exhaustive search was carried out up to July 2018 in MEDLINE (Ovid), Embase, Scopus, and Web of Science. RESULTS: The concepts of TV and VBP are related; value frameworks for medicines should include social preferences, comparative effectiveness, safety, adoption viability, social impact, high quality of evidence, severity of illness, and innovation. The added therapeutic value (ATV) is the manner of measuring the therapeutic advantages of new medicines compared with existing ones in terms of comparative effectiveness and safety. There are variations in the mechanisms of reimbursement and drug pricing regulation between the countries of study. CONCLUSION: In a VBP system it is essential to establish the TV and ATV of a new medicine. Although there are no methodological guidelines for the implementation of VBP policies, the process implies from the beginning the definition of TV categories that will be included in the drug pricing and reimbursement systems. Agreements between the pharmaceutical industry and governments have become a useful tool as a negotiating mechanism in most countries.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Internacionalidade / Usos Terapêuticos / Seguro de Saúde Baseado em Valor Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Internacionalidade / Usos Terapêuticos / Seguro de Saúde Baseado em Valor Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos